Y3L: EQ-5D-Y-3L value set data
In eq5d: Methods for Analysing 'EQ-5D' Data and Calculating 'EQ-5D' Index Scores
Y3L R Documentation
EQ-5D-Y-3L value set data
Description
EQ-5D-Y-3L value set calculation data for Belgium, Brazil, China, Germany, Hungary,
Indonesia, Japan, Netherlands, Slovenia and Spain.
Usage
Y3L
Format
An object of class data.frame with 14 rows and 10 columns.
Source
Belgium: Dewilde S, Roudijk B, Tollenaar NH, Ramos-Goñi JM. An EQ-5D-Y-3L Value Set for Belgium. Pharmacoeconomics. 2022 Nov 1:1–12. doi: 10.1007/s40273-022-01187-x. Epub ahead of print. PubMed
Brazil: Espirito Santo CM, Miyamoto GC, Santos VS, Ben ÂJ, Finch AP, Roudijk B, de Jesus-Moraleida FR, Stein AT, Santos M, Yamato TP. Estimating an EQ-5D-Y-3L Value Set for Brazil. Pharmacoeconomics. 2024 Jul 2. doi: 10.1007/s40273-024-01404-9. Epub ahead of print. PubMed
China: Yang Z, Jiang J, Wang P, Jin X, Wu J, Fang Y, Feng D, Xi X, Li S, Jing M, Zheng B, Huang W, Luo N. Estimating an EQ-5D-Y-3L Value Set for China. Pharmacoeconomics. 2022 Nov 18. doi: 10.1007/s40273-022-01216-9. Epub ahead of print. PubMed
Germany: Kreimeier S, Mott D, Ludwig K, Greiner W; IMPACT HTA HRQoL Group. EQ-5D-Y Value Set for Germany. Pharmacoeconomics. 2022 May 23:1–13. doi: 10.1007/s40273-022-01143-9. Epub ahead of print. PubMed
Hungary: Rencz F, Ruzsa G, Bató A, Yang Z, Finch AP, Brodszky V. Value Set for the EQ-5D-Y-3L in Hungary. Pharmacoeconomics. 2022 Sep 20:1–11. doi: 10.1007/s40273-022-01190-2. Epub ahead of print. PubMed
Indonesia: Fitriana TS, Roudijk B, Purba FD, Busschbach JJV, Stolk E. Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values. Pharmacoeconomics. 2022 Nov 9. doi: 10.1007/s40273-022-01210-1. Epub ahead of print. PubMed
Japan: Shiroiwa T, Ikeda S, Noto S, Fukuda T, Stolk E. Valuation Survey of EQ-5D-Y Based on the International Common Protocol: Development of a Value Set in Japan. Med Decis Making. 2021 Mar 23:272989X211001859. doi: 10.1177/0272989X211001859. Epub ahead of print. PubMed
Netherlands:Roudijk B, Sajjad A, Essers B, Lipman S, Stalmeier P, Finch AP. A Value Set for the EQ-5D-Y-3L in the Netherlands. Pharmacoeconomics. 2022 Oct 10:1–11. doi: 10.1007/s40273-022-01192-0. Epub ahead of print. PubMed
Slovenia: Prevolnik Rupel V, Ogorevc M; IMPACT HTA HRQoL Group. EQ-5D-Y Value Set for Slovenia. Pharmacoeconomics. 2021 Feb 10. doi: 10.1007/s40273-020-00994-4. Epub ahead of print. PubMed
Spain: Ramos-Goñi JM, Oppe M, Estévez-Carrillo A, Rivero-Arias O; IMPACT HTA HRQoL Group. Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data. Value in Health. 2021 Dec 04. doi: 10.1016/j.jval.2021.10.013.
eq5d documentation built on Sept. 11, 2024, 7:34 p.m.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
| Y3L | R Documentation |
EQ-5D-Y-3L value set data
Description
EQ-5D-Y-3L value set calculation data for Belgium, Brazil, China, Germany, Hungary, Indonesia, Japan, Netherlands, Slovenia and Spain.
Usage
Y3L
Format
An object of class data.frame with 14 rows and 10 columns.
Source
Belgium: Dewilde S, Roudijk B, Tollenaar NH, Ramos-Goñi JM. An EQ-5D-Y-3L Value Set for Belgium. Pharmacoeconomics. 2022 Nov 1:1–12. doi: 10.1007/s40273-022-01187-x. Epub ahead of print. PubMed
Brazil: Espirito Santo CM, Miyamoto GC, Santos VS, Ben ÂJ, Finch AP, Roudijk B, de Jesus-Moraleida FR, Stein AT, Santos M, Yamato TP. Estimating an EQ-5D-Y-3L Value Set for Brazil. Pharmacoeconomics. 2024 Jul 2. doi: 10.1007/s40273-024-01404-9. Epub ahead of print. PubMed
China: Yang Z, Jiang J, Wang P, Jin X, Wu J, Fang Y, Feng D, Xi X, Li S, Jing M, Zheng B, Huang W, Luo N. Estimating an EQ-5D-Y-3L Value Set for China. Pharmacoeconomics. 2022 Nov 18. doi: 10.1007/s40273-022-01216-9. Epub ahead of print. PubMed
Germany: Kreimeier S, Mott D, Ludwig K, Greiner W; IMPACT HTA HRQoL Group. EQ-5D-Y Value Set for Germany. Pharmacoeconomics. 2022 May 23:1–13. doi: 10.1007/s40273-022-01143-9. Epub ahead of print. PubMed
Hungary: Rencz F, Ruzsa G, Bató A, Yang Z, Finch AP, Brodszky V. Value Set for the EQ-5D-Y-3L in Hungary. Pharmacoeconomics. 2022 Sep 20:1–11. doi: 10.1007/s40273-022-01190-2. Epub ahead of print. PubMed
Indonesia: Fitriana TS, Roudijk B, Purba FD, Busschbach JJV, Stolk E. Estimating an EQ-5D-Y-3L Value Set for Indonesia by Mapping the DCE onto TTO Values. Pharmacoeconomics. 2022 Nov 9. doi: 10.1007/s40273-022-01210-1. Epub ahead of print. PubMed
Japan: Shiroiwa T, Ikeda S, Noto S, Fukuda T, Stolk E. Valuation Survey of EQ-5D-Y Based on the International Common Protocol: Development of a Value Set in Japan. Med Decis Making. 2021 Mar 23:272989X211001859. doi: 10.1177/0272989X211001859. Epub ahead of print. PubMed
Netherlands:Roudijk B, Sajjad A, Essers B, Lipman S, Stalmeier P, Finch AP. A Value Set for the EQ-5D-Y-3L in the Netherlands. Pharmacoeconomics. 2022 Oct 10:1–11. doi: 10.1007/s40273-022-01192-0. Epub ahead of print. PubMed
Slovenia: Prevolnik Rupel V, Ogorevc M; IMPACT HTA HRQoL Group. EQ-5D-Y Value Set for Slovenia. Pharmacoeconomics. 2021 Feb 10. doi: 10.1007/s40273-020-00994-4. Epub ahead of print. PubMed
Spain: Ramos-Goñi JM, Oppe M, Estévez-Carrillo A, Rivero-Arias O; IMPACT HTA HRQoL Group. Accounting for Unobservable Preference Heterogeneity and Evaluating Alternative Anchoring Approaches to Estimate Country-Specific EQ-5D-Y Value Sets: A Case Study Using Spanish Preference Data. Value in Health. 2021 Dec 04. doi: 10.1016/j.jval.2021.10.013.
R Package Documentation
Browse R Packages
We want your feedback!
Note that we can't provide technical support on individual packages. You should contact the package authors for that.
Embedding an R snippet on your website
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.